These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 169759)

  • 1. [Antibodies in patients with cervicouterine carcinoma].
    Gomez-Estrada H; Huerta-Sanchez R; Hernandez-Sanchez R; Garza-Eufrasio O; Venustiano-Carranza J; Miranda-Acevedo C; Terrazas-Flores JA; Fernandez-Quintero P
    Arch Invest Med (Mex); 1975; 6(1):13-22. PubMed ID: 169759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial purification and characterization of tumor associated antigen in cervical carcinoma.
    Das S; Chatterjee R; Chattopadhyay U; Roy Chowdhury J
    Neoplasma; 1985; 32(1):21-30. PubMed ID: 2580245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus-specific antigens in exfoliated cervical cells from women with and without cervical anaplasia.
    Pacsa AS; Kummerländer L; Pejtsik B; Krommer K; Pali K
    Cancer Res; 1976 Jul; 36(7 PT 1):2130-2. PubMed ID: 179696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-embryoglycan antibodies detected in sera of patients with uterine cervical cancer].
    Kato Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):129-35. PubMed ID: 1690252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exfoliative immunocytology of cervical carcinoma.
    Efthymiou CJ; Smulewicz JJ
    Arch Pathol Lab Med; 1977 Nov; 101(11):575-8. PubMed ID: 334107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of herpes simplex virus type-2 antigen(s) in biopsies from carcinoma of the uterine cervix.
    Thankamani V; Kumari TV; Vasudevan DM
    J Exp Pathol; 1985; 2(2):123-33. PubMed ID: 2431113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated antigens in cervical cancer tissues and in sera from patients with cervical cancer or with head and neck cancer.
    Ibrahim AN; Robinson RA; Marr L; Abdelal AT; Nahmias AJ
    J Natl Cancer Inst; 1979 Aug; 63(2):319-23. PubMed ID: 88537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigens of carcinoma of the cervix uteri. A study by means of immunofluorescence.
    Nelson DS
    Clin Exp Immunol; 1974 Jan; 16(1):53-62. PubMed ID: 4619779
    [No Abstract]   [Full Text] [Related]  

  • 9. [Detection of antitumor-antibodies in patients with tonsillar carcinoma (author's transl)].
    Mang WL; Hammer C; Gruber F; Weinfurtner F; Allmeling A; Brendel W
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):11-5. PubMed ID: 7012490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood group isoantigen expression during tumour progression of cervical neoplasia.
    Stendahl U; Lindgren A; Busch C
    Anticancer Res; 1987; 7(6):1285-6. PubMed ID: 3442419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oncogen infectious nucleoprotein and herpes virus hominis type 2 in stages of cervical cancer. Investigatious by indirect immunofluorescens].
    Eschbach W; Glathe H; NOBEL B; Bergmann U
    Arch Geschwulstforsch; 1974; 44(3):246-59. PubMed ID: 4376680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood group antigen expression and prognosis in squamous cell carcinoma of the uterine cervix.
    Lindgren A; Stendahl U; Brodin T; Lundblad A; Sällström J; Busch C
    Anticancer Res; 1986; 6(2):255-8. PubMed ID: 2423015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of immunofluorescence from oral swabs in patients with tonsillar carcinoma.
    Mang WL; Hammer C
    J Med; 1981; 12(6):447-53. PubMed ID: 7033427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of circulating immune complexes and associated parameters in patients with cervix uteri cancer].
    Orozco-Cruz R; Aguilar-Santelises M; Rodríguez-Coquiez G; Estrada Parra S
    Rev Latinoam Microbiol; 1987; 29(2):145-51. PubMed ID: 3438604
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunohistochemical study of cells of invasive cancer of the vaginal part of the cervix uteri].
    Raĭchlin NT; Dobrynin VA; Petrov SV; Serre D
    Vopr Onkol; 1990; 36(3):314-8. PubMed ID: 1691888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A tumor-associated antigen of cervical cancer].
    Ermoshina NV; Ievleva ES; Ageenko AI; Kogan IIa; Tsukerman BG
    Eksp Onkol; 1986; 8(2):48-51. PubMed ID: 3084195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
    Dostal V; Fanta D; Reiss-Gutfreund RJ; Janisch H; Berger R
    Wien Klin Wochenschr; 1977 Mar; 89(6):201-3. PubMed ID: 191994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
    Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
    Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes type-2 virus antigens in human cervical carcinoma.
    Adelusi B; Osunkoya BO; Fabiyi A
    Obstet Gynecol; 1976 May; 47(5):545-8. PubMed ID: 772507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.